Download the Materials

Our Business

Discover TOHO HOLDINGS

Discover TOHO HOLDINGS

Our Business TOP

Pharmaceutical Wholesaling Business

Pharmaceutical Wholesaling Business
Dispensing Pharmacy Business

Dispensing Pharmacy Business

Pharmaceutical Manufacturing and Sales Business

Pharmaceutical Manufacturing and Sales Business

Others

Others

Corporate Information

Corporate Information TOP

Investor Relations

TOHO HOLDINGS at a Glance

TOHO HOLDINGS at a Glance

Investor Relations TOP

Sustainability

Sustainability TOP

 

Corporate Information

Executives

Director

  • Representative Director,
    President and CEO

    Hiromi Edahiro

    Representative Director,
    President and CEO

    Hiromi Edahiro

    Biography

    • Joined Tokio Marine Fire Insurance (current Tokio Marine & Nichido Fire Insurance Co., Ltd.)

    • Joined Tokiwa Pharmaceutical

    • Representative Director and President of Tokiwa Pharmaceutical

    • Auditor of the Company

    • President and Representative Director of TOHO PHARMACEUTICAL

    • Director of the Company

    • Vice President and Director of the Company

    • Director of TOHO PHARMACEUTICAL

    • Vice Chairman of the Board and CFO, Representative Director of the Company

    • Chairperson of the Board and Representative Director of TOHO PHARMACEUTICAL

    • Director of the Company

    • Director of TOHO PHARMACEUTICAL (to present)

    • Representative Director, CFO of the Company

    • Representative Director, CEO and CFO of the Company

    • Representative Director, President and CEO of the Company (to present)

  • Senior Executive Managing Director and COO

    Akira Umada

    Senior Executive Managing Director and COO

    Akira Umada

    Biography

    • Joined TOHO PHARMACEUTICAL (current the Company)

    • Corporate Officer of TOHO PHARMACEUTICAL

    • Director of TOHO PHARMACEUTICAL

    • Managing Director of TOHO PHARMACEUTICAL

    • Corporate Officer of the Company

    • Senior Managing Director of TOHO PHARMACEUTICAL

    • Director of the Company

    • President and Representative Director of TOHO PHARMACEUTICAL (to present)

    • Senior Executive Managing Director of the Company

    • Senior Executive Managing Director, COO of the Company

    • Senior Executive Managing Director and COO of the Company (to present)

  • Executive Managing Director and CGO

    Takeo Matsutani

    Executive Managing Director and CGO

    Takeo Matsutani

    Biography

    • Joined TOHO PHARMACEUTICAL (current the Company)

    • Director of TOHO PHARMACEUTICAL

    • Managing Director of TOHO PHARMACEUTICAL

    • Senior Managing Director of TOHO PHARMACEUTICAL

    • Director of the Company

    • Executive Managing Director of Kyushu Toho

    • President and Representative Director of Kyushu Toho

    • Vice President and Director of TOHO PHARMACEUTICAL (to present)

    • Chairperson of the Board and Director of Kyushu Toho (to present)

    • Executive Managing Director and CGO of the Company (to present)

  • Executive Managing Director,
    in charge of Transformation

    Shuzo Kono

    Executive Managing Director,
    in charge of Transformation

    Shuzo Kono

    Biography

    • Joined Sun Microsystems, Inc. (current ORACLE CORPORATION JAPAN)

    • Joined TOHO PHARMACEUTICAL (current the Company)

    • Joined OMWELL INC. (current SAYWELL inc.)

    • Corporate officer of SAYWELL inc.

    • Director of SAYWELL inc.

    • President and Representative Director of SAYWELL inc. (to present)

    • Director of TOHO PHARMACEUTICAL

    • Corporate officer of TOHO PHARMACEUTICAL

    • Corporate officer of the Company

    • Director of TOHO PHARMACEUTICAL (to present)

    • Director and Corporate Officer, in charge of Transformation of the Company

    • Executive Managing Director, in charge of Transformation (to present)

Outside Director

  • Outside Director

    Manako Haga

    Outside Director

    Manako Haga

    Biography

    • Joined J.P. Morgan Trust Bank Ltd.

    • Joined James Kaepel Securities

    • Joined SG Warburg Securities Co., Ltd.

    • Joined Klein Oat Benson Investment Management Co., Ltd.

    • Joined Merrill Lynch Investment Managers, Inc.

    • Joined Fidelity Asset Management Co., Ltd.

    • Director of Fidelity Asset Management Co., Ltd. and Fidelity Securities Co., Ltd.
      General Manager of Finance Department and President's Office Business Manager

    • Advisor of Matsui Securities Co., Ltd.

    • Joined The British School in Tokyo

    • Director of Matsui Securities Co., Ltd.

    • Director and HR & General Affairs of Matsui Securities Co., Ltd.

    • Outside Director of the Company (to present)

    • Executive Officer and HR & General Affairs of Matsui Securities Co., Ltd.

    • Executive Officer of Matsui Securities Co., Ltd. (to present)

  • Outside Director

    Masahiko Ito

    Outside Director

    Masahiko Ito

    Biography

    • Joined Fujikura Insulated Wire & Cable Co. (current Fujikura Ltd.)

    • Corporate Officer and General Manager of Superconductor Business Development Division, New Business Development Center, Fujikura Ltd.

    • Managing Corporate Officer, Deputy Chief of Power & Telecommunication Systems Company, in charge of Infrastructure Business Segment, and General Manager of Superconductor Business Development Division, New Business Development Center, Fujikura Ltd.

    • Managing Corporate Officer, Deputy Chief of Power & Telecommunication Systems Company, Fujikura Ltd.

    • Director and Managing Corporate Officer, Deputy Chief of Power & Telecommunication Systems Company, Fujikura Ltd.

    • Representative Director and President, Fujikura Ltd.

    • Chairperson, The Japanese Electric Wire & Cable Makers’Association

    • Representative Director, President and CEO, Fujikura Ltd.

    • Director and Chairperson, Chairperson of the Board of Directors, Fujikura Ltd.

    • Chairperson, The Japanese Electric Wire & Cable Makers’Association

    • Outside Director, Toagosei Co., Ltd.

    • Director and Chairperson, Fujikura Ltd.

    • Honorary Advisor, Fujikura Ltd.

    • Outside Director, TechnoPro Holdings, Inc.

    • Outside Director of the Company (to present)

  • Outside Director of Audit and Supervisory Committee Members

    Hidehito Kotani

    Outside Director of Audit and
    Supervisory Committee Members

    Hidehito Kotani

    Biography

    • Joined Pfizer, Inc. (USA), Connecticut State World Central Research Institute

    • Joined Banyu Pharmaceutical Co., Ltd. (current MSD K.K.)

    • Corporate Officer in charge of Corporate Services and General Manager of the President's Office of Banyu Pharmaceutical Co., Ltd.

    • Vice President, Corporate Officer, General Manager of Sales Division, General Manager of President's Office of MSD K.K.

    • Vice President of Merck & Co., Inc. (USA)

    • Representative Director and President, CEO and CTO of Panasonic Healthcare Holdings Corporation (current PHC Holdings Corporation)

    • Representative of Frederick Research GK (to present)

    • Representative Director of Novocure Corporation (to present)

    • Outside Director (Audit and Supervisory Committee Member) of the Company (to present)

  • Outside Director of Audit and Supervisory Committee Members

    Chie Goto

    Outside Director of Audit and
    Supervisory Committee Members

    Chie Goto

    Biography

    • Joined Société World Corporation.

    • Joined Tokyo Student Career Information Center Co.

    • Joined Yamada & Partners Accounting Office

    • Registered as a lawyer and joined Sakura Kyodo Law Office

      Registered as a Certified Public Accountant

    • Partner, Sakura Kyodo Law Office (to present)

    • Corporate Auditor (outside) of AVANT CORPORATION (current AVANT GROUP CORPORATION)

    • Audit and Supervisory Committee Member (Outside Director) of AVANT GROUP CORPORATION (to present)

    • Outside Director (Audit and Supervisory Committee Member) of the Company (to present)

  • Outside Director of Audit and Supervisory Committee Members

    Miho Saito

    Outside Director of Audit and
    Supervisory Committee Members

    Miho Saito

    Biography

    • Joined Nomura Securities Co., Ltd.

    • Joined Credit Suisse Trust & Banking

    • Joined SPARX Asset Management Co., Ltd. (current SPARX Group Co., Ltd.)

    • Joined Government of Singapore Investment Corporation (GIC)

    • Joined Clay Finlay Inc

    • Joined United Nations Joint Staff Pension Fund

    • Executive Officer of Strategy Advisors Co., Ltd.

    • Outside Director (Audit and Supervisory Committee Member) of ELAN Corporation (to present)

    • Outside Director of Yamaguchi Financial Group, Inc. (to present)

      Outside Director (Audit and Supervisory Committee Member) of the Company (to present)

    • Outside Director (Audit and Supervisory Committee Member) of SPARX Group Co., Ltd. (to present)

Corporate Officer

  • Senior Executive Corporate Officer

    Makoto Kawamura

  • Executive Corporate Officer and CFO

    Yasuo Sakae

  • Executive Corporate Officer

    Shigeki Nakata

  • Corporate Officer

    Kengo Ogawa

  • Corporate Officer

    Kazuki Shimizu

  • Corporate Officer

    Aya
    Komai

  • Corporate Officer

    Aiko Noshiro

  • Corporate Officer

    Takuya Narikawa

  • Corporate Officer

    Takeshi Sakamoto

  • Corporate Officer

    Wataru Tani

  • Corporate Officer

    Kaoru Kamo

  • Corporate Officer

    Tomoji Hashiba

Skills Matrix for Directors and Audit and Supervisory Committee Members

Skills Matrix

Name Corporate Management Finance & Accounting / Capital Markets Human Resource and Organizational Development / Sustainability Legal Affairs & Risk Management Sales Strategy / Logistics Business Development / DX Knowledge of Pharmaceutical Administration and Policy
Hiromi Edahiro ○ ○ ○ ○
Akira Umada ○ ○ ○ ○
Takeo Matsutani ○ ○ ○ ○ ○ ○
Shuzo Kono ○ ○ ○ ○
Manako Haga ○ ○ ○
Masahiko Ito ○ ○ ○ ○
Hidehito Kotani ○ ○ ○ ○ ○
Chie Goto ○ ○ ○
Miho Saito ○ ○ ○

Reasons for Selecting Skills

skills Reason for selection
Corporate Management We believe that a wide range of knowledge and experience in corporate management is necessary to formulate and implement growth strategies from a medium- to long-term perspective in the midst of significant changes in the market environment.
Finance & Accounting /
Capital Markets		 We believe that a wide range of knowledge and experience in finance, accounting and capital markets is necessary to realize sustainable growth investment and shareholder returns aimed at increasing corporate value while improving capital efficiency and securing a stable financial base.
Human Resource and Organizational Development / Sustainability Human Resource and Organizational Development:
We believe that knowledge and experience in human resource and organizational development are necessary in order to appropriately advise and supervise human resource development and personnel system reforms aimed at maximizing the value of human capital, which is an important foundation for sustainable corporate growth.
Sustainability:
We believe that knowledge and experience in the sustainability field are necessary to achieve the qualitative improvement of sustainability management.
Legal Affairs & Risk Management In order to increase corporate value as a sustainable company, it is important to develop and enhance the governance system and strengthen the risk management system, which form the basis for this. To this end, we believe that knowledge and experience in legal affairs and risk management are necessary.
Sales Strategy / Logistics Sales Strategy:
In order to co-create new value through the provision of unique services, it is important to strengthen our ability to understand customer needs and to provide added value. We believe that a wide range of 15 knowledge and experience in sales strategy is necessary to accurately grasp current issues and their impact on market changes, and to appropriately advise and supervise the Group’s sales strategies and policies.
Logistics:
As a company that handles life-related products, we believe that "safe and secure pharmaceutical distribution" is our mission, and that knowledge and experience in logistics are necessary to formulate, advise, and supervise appropriate logistics strategies.
Business Development / DX In order to enhance the Group's corporate value over the medium to long term, it is important to establish new businesses as early as possible, reform existing businesses, and improve operational efficiency. We believe that knowledge and experience in business development and DX are necessary to implement and promote these initiatives.
Knowledge of Pharmaceutical Administration and Policy We believe that in the complex market environment of the pharmaceutical industry, where national systems play a major role, knowledge and experience in pharmaceutical administration and policy are necessary to achieve sustainable growth and increase corporate value over the medium to long term.

Corporate Information